Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)
Condition(s):Dry Eye; Ocular Graft vs Host Disease; Meibomian Gland DysfunctionLast Updated:November 8, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Dry Eye; Ocular Graft vs Host Disease; Meibomian Gland DysfunctionLast Updated:November 8, 2019Terminated
Condition(s):Geographic Atrophy; Macular DegenerationLast Updated:April 23, 2019Terminated
Condition(s):Rhegmatogenous Macula-off Retinal DetachmentLast Updated:April 24, 2013Completed
Condition(s):Presbyopia; PseudophakiaLast Updated:January 31, 2019Unknown status
Condition(s):Prostate CancerLast Updated:September 27, 2018Completed
Condition(s):Open-angle Glaucoma; Ocular HypertensionLast Updated:November 24, 2011Completed
Condition(s):Intraoperative Floppy Iris SyndromeLast Updated:April 20, 2022Completed
Condition(s):Capillary MalformationsLast Updated:April 16, 2019Terminated
Condition(s):Erythematous RosaceaLast Updated:February 18, 2021Completed
Condition(s):Glaucoma, Open-AngleLast Updated:April 24, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.